[Federal Register: February 26, 2010 (Volume 75, Number 38)]
[Notices]
[Page 8980-8981]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26fe10-95]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3223-N]
Medicare Program; Meeting of the Medicare Evidence Development
and Coverage Advisory Committee--April 21, 2010
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces that a public meeting of the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC)
(``Committee'') will be held on Wednesday, April 21, 2010. The
Committee generally provides advice and recommendations concerning the
adequacy of scientific evidence needed to determine whether certain
medical items and services should be covered under the Medicare
statute. This meeting will focus on the currently available evidence
regarding the risks, benefits, and outcomes of radiation therapy,
inclusive of external beam radiotherapy (EBRT) and brachytherapy, for
the treatment of localized prostate cancer. This meeting is open to the
public in accordance with the Federal Advisory Committee Act (5 U.S.C.
App. 2, section 10(a)).
DATES: Meeting date: The public meeting will be held on Wednesday,
April 21, 2010 from 7:30 a.m. until 4:30 p.m., eastern daylight time
(e.d.t.).
Deadline for Submission of Written Comments: Written comments must
be received at the address specified in the ADDRESSES section of this
notice by 5 p.m., e.d.t. on March 22, 2010. Once submitted all comments
are final.
Deadlines for Speaker Registration and Presentation Materials: The
deadline to register to be a speaker and to submit Powerpoint
presentation materials and writings that will be used in support of an
oral presentation, is 5 p.m., e.d.t. on Monday, March 22, 2010.
Speakers may register by phone or via e-mail by contacting the person
listed in the FOR FURTHER INFORMATION CONTACT section of this notice.
Presentation materials must be received at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees Registration: Individuals may
register via e-mail at MEDCAC_Registration@cms.hhs.gov or by phone by
contacting the person listed in the FOR FURTHER INFORMATION CONTACT
section of this notice by 5 p.m., e.d.t. on Wednesday, April 14, 2010.
Deadline for Submitting a Request for Special Accommodations:
Persons attending the meeting who are hearing or visually impaired, or
have a condition that requires special assistance or accommodations,
are asked to contact the Executive Secretary for MEDCAC as specified in
the FOR FURTHER INFORMATION CONTACT section of this notice no later
than 5 p.m., e.d.t. Friday, April 2, 2010.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Boulevard, Baltimore, MD 21244.
Submission of Presentations and Comments: Presentation materials
and written comments that will be presented at the meeting must be
submitted via e-mail to MedCACpresentations@cms.hhs.gov or by regular
mail to the contact listed in the FOR FURTHER INFORMATION CONTACT
section of this notice by the date specified in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Coverage and Analysis Group, C1-09-06, 7500
Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone
(410-786-0309) or via e-mail at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
MEDCAC, formerly known as the Medicare Coverage Advisory Committee
(MCAC), provides advice and recommendations to CMS regarding clinical
issues. (For more information on MCAC, see the December 14, 1998
Federal Register (63 FR 68780).) This notice announces the April 21,
2010, public meeting of the Committee. During this meeting, the
Committee will discuss the currently available evidence regarding the
risks, benefits and outcomes of radiation therapy, inclusive of EBRT
and brachytherapy, for the treatment of localized prostate cancer.
Background information about this topic, including panel materials, is
available at http://www.cms.hhs.gov/coverage. We encourage the
participation of appropriate organizations with expertise in radiation
therapy for the treatment of localized prostate cancer.
[[Page 8981]]
II. Meeting Format
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 45 minutes. The
Committee may limit the number and duration of oral presentations to
the time available. Your comments should focus on issues specific to
the list of topics that we have proposed to the Committee. The list of
research topics to be discussed at the meeting will be available on the
following Web site prior to the meeting: http://www.cms.hhs.gov/mcd/
index_list.asp?list_type=mcac. We require that you declare at the
meeting whether you have any financial involvement with manufacturers
(or their competitors) of any items or services being discussed.
The Committee will deliberate openly on the topics under
consideration. Interested persons may observe the deliberations, but
the Committee will not hear further comments during this time except at
the request of the chairperson. The Committee will also allow a 15-
minute unscheduled open public session for any attendee to address
issues specific to the topics under consideration. At the conclusion of
the day, the members will vote and the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS's Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. You may register by contacting the person listed in
the FOR FURTHER INFORMATION CONTACT section of this notice by the
deadline listed in the DATES section of this notice. Please provide
your full name (as it appears on your state-issued driver's license),
address, organization, telephone, fax number(s), and e-mail address.
You will receive a registration confirmation with instructions for your
arrival at the CMS complex or you will be notified the seating capacity
has been reached.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. We recommend that
confirmed registrants arrive reasonably early, but no earlier than 45
minutes prior to the start of the meeting, to allow additional time to
clear security. Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means
of all persons entering the building. We note that all items brought
into CMS, whether personal or for the purpose of presentation or to
support a presentation, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45
minutes prior to the convening of the meeting. All visitors must be
escorted in areas other than the lower and first floor levels in the
Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: February 4, 2010.
Barry M. Straube,
Chief Medical Officer and Director, Office of Clinical Standards and
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2010-3724 Filed 2-25-10; 8:45 am]
BILLING CODE 4120-01-P